Main

It is well established that, following preterm birth, male infants have poorer neonatal outcomes and a greater incidence of death than do females of the same gestational age (1, 2, 3, 4). Male preterm infants require more initial respiratory and circulatory support than do females of the same gestational age, take longer to achieve targeted arterial oxygen saturation levels, have a greater oxygen dependency at 36 weeks’ postmenstrual age, have longer hospital stays, have an increased incidence of RDS, BPD, and pulmonary hemorrhage, and have a greater requirement for postnatal corticosteroids (1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12). Evidence indicates that the “male disadvantage” in respiratory function is largely a result of lung immaturity relative to females. The respiratory “male disadvantage” following preterm birth continues throughout infancy, with preterm males exhibiting greater respiratory morbidity, including poorer lung function and an increased use of bronchodilators or inhaled steroids up to 24 months of age, independent of neonatal outcomes (6, 7, 13).

Studies in humans and laboratory animals have demonstrated that maturation of the pulmonary surfactant system, including the secretion of surfactant during gestation, is delayed in males relative to females, and sex differences in the composition of pulmonary surfactant have been demonstrated in several species (14, 15, 16, 17, 18, 19). Pulmonary surfactant comprises ~90% lipids, of which 90–95% are phospholipids. It contains seven major classes of phospholipids, with phosphatidylcholine (PC; also referred to as lecithin (L)) being the most abundant and the disaturated PC species dipalmitoylphosphatidylcholine (DPPC; also denoted as PC 16:0/16:0 or PC 32:0) having the greatest ability to reduce surface tension to near 0 mN/m under compression (20). As such, PCs are often used in indices of lung maturity. Based on surfactant composition (ratio of PC to sphingomyelin (S), the concentration and proportion of disaturated PC, and the proportion of phosphatidylglycerol (PG)), it has been suggested that, in the last 2 months of human gestation, lung maturation in male fetuses is retarded, relative to that in female fetuses, by 1.2–2.5 weeks (16, 17). Similarly, analyses of lung lavage and amniotic fluid from preterm fetal rabbits showed that females displayed an earlier increase in saturated PC/S and total PC/S ratios than did males (18).

Previous studies on sex differences in human lung maturation have focused on the major surfactant phospholipids, especially PC and its saturated species, primarily during late gestation; however, there is a paucity of data on differences in the composition of other surfactant phospholipids between males and females at earlier stages of fetal life, which could contribute to the male disadvantage in respiratory morbidity and mortality observed after very preterm birth. Therefore, our aim was to determine whether the composition of pulmonary phospholipids differs in newborn male and female preterm infants, and whether differences are related to gestational age. In order to analyze surfactant phospholipid composition, we have used gastric aspirates, samples of which have been used previously to assess surfactant maturity in preterm infants (21, 22). Gastric aspirate is likely to provide an index of lung maturity because, prior to the onset of feeding after birth, it primarily consists of ingested lung fluid and amniotic fluid, both of which are expected to contain pulmonary surfactant. We hypothesized that male infants born very preterm have altered surfactant phospholipid composition compared with females of the same gestational age at birth. We further hypothesized that sex differences in surfactant phospholipid composition differ with gestational age.

Methods

Sample Collection

This study was approved by the Human Research Ethics Committee of The Royal Women’s Hospital, Melbourne, Australia. Gastric aspirate samples were collected within 1 h after birth from male and female infants born at <30 weeks of gestation (25+0 days–29+6 days (25–29+6) weeks of gestation; see Table 1) at The Royal Women’s Hospital between May 2010 and September 2012. Samples were collected from a maximum of 10 infants of each sex at each gestational week of birth within 1 h of birth; however, samples from only seven males and seven females could be obtained for the 25-week group (25–25+6 weeks), and from five males in the 27-week group (27–27+6 weeks; Table 1). Samples from any infants with a congenital abnormality were excluded.

Table 1 Demographic data of male and female preterm infants whose gastric fluid was sampled and collected for surfactant phospholipid analysis

Infants recruited into this study were those who required respiratory support in the form of either intubation and ventilation or continuous positive airway pressure (CPAP) from birth; these infants routinely have a nasogastric or orogastric (NG/OG) feeding tube (5/6 Fr.) inserted soon after birth in order to vent air from the stomach following initial resuscitation. To ensure that the tip of the NG/OG tube is in the stomach, fluid is aspirated (0.5–1 ml) using a small syringe. The aspirated fluid is then tested on litmus paper to confirm its acidity and hence the correct positioning of the tube tip. For the present study, we took advantage of the fact that these infants would be routinely fitted with a NG/OG tube and have gastric samples aspirated. We obtained informed parental consent allowing us to keep the gastric aspirate samples for analysis, which otherwise would have been discarded. Samples were chilled and then stored at −80 °C until analysis.

Surfactant Phospholipid Analysis

Phospholipids in the gastric aspirate samples including the molecular species within the major phospholipid classes (lysophosphatidylcholine (LPC), PC, phosphatidylethanolamine (PE), PG, phosphatidylinositol (PI), phosphatidylserine (PS) and S) were isolated and then analyzed by electrospray ionization tandem mass spectrometry (PE Sciex API 4000 Q/TRAP; Framingham, MA) using a turbo-ion spray source and Analyst data system, as previously described (23). Briefly, phospholipids were extracted from gastric aspirate samples (50 μl) with 2:1 chloroform-methanol (1,000 μl) following the addition of internal standards (S 30:1, PC 13:0/13:0, LPC 13:0, PE 17:0/17:0, PS 17:0/17:0, and PG 17:0/17:0 (Avanti Polar Lipids, Alabaster, AL)). Liquid chromatographic separation was conducted on a 1.8 μm, 50 × 2.1 mm C18 column (Zorbax; Agilent Technologies, Santa Clara, CA) at 300 μl/min using gradient conditions previously described (23). Individual lipids were quantified using scheduled multiple reactions monitoring in positive-ion mode and their concentrations calculated by relating the peak area of the lipid species to the peak area of the corresponding internal standard (23). The concentrations of all individual lipid species within each class were added to calculate the total concentration of each class of phospholipid; the total concentrations of each class of phospholipid were then added to calculate the total phospholipid concentration. Each individual molecular species within each phospholipid class was expressed as a molar percentage of its respective phospholipid class. Each phospholipid class was expressed as a molar percentage of the total phospholipids measured. Molecular species are denoted as either A:x/B:y or A+B:x+y, where A and B are the number of carbon atoms in the fatty acid chains esterified at the sn-1 and sn-2 positions, respectively, and x and y are the number of double bonds in the fatty acid chains.

Statistical Analysis

Demographic data are presented as mean (SD) or median (range) as appropriate. These data were compared using Fisher’s exact test for categorical data, Student’s t-test for continuous variables, and Mann–Whitney’s U-test for non-parametric data. Phospholipid data are presented as mean±SEM. Data were evaluated for normality using a Shapiro–Wilk test, and data were transformed where appropriate. The phospholipid composition of the gastric aspirate samples collected from infants born between 25 and 29+6 weeks of gestation was analyzed using a two-way analysis of variance, with sex (PS) and age (PA; i.e., gestational age at birth) as factors. If there was a significant effect of gestational age, a least significant difference post hoc test was conducted to determine differences in phospholipid composition between each gestational week at birth. If there was a significant interaction effect (PS × A), an unpaired Student’s t-test was conducted to compare the phospholipid composition between males and females at each gestational week of birth. Statistical significance was set at P<0.05.

Results

Demographic Data

The demographic details of the preterm infants used in our study are shown in Table 1. There were no statistically significant differences in any of the variables analyzed between male and female infants at each gestational week of birth.

Phospholipid Classes

No overall effects of sex, gestational age, or interactions between these factors were present in the proportions of LPC (Figure 1a), PC (Figure 1b), PE (Figure 1c), PG (Figure 1d), and PS (Figure 1f) relative to the total amount of phospholipids measured. An overall sex effect and interaction effect were observed in the proportions of PI (Figure 1e) and S (Figure 1g); males overall (i.e., all males as a group) had a higher proportion of PI (most notable at 26 and 27 weeks of gestation) and a lower proportion of S (most notable at 27 weeks of gestation) than did females. In addition, the proportion of S in samples from males and females combined changed with gestational age at birth, with the proportion of S being higher at 25 weeks than at 26 and 28 weeks, and higher at 27 weeks compared with that at 28 weeks.

Figure 1
figure 1

Class composition of phospholipids. (a) Proportion of phospholipid class lysophosphatidylcholine (LPC) in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (b) Proportion of phospholipid class phosphatidylcholine (PC) in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (c) Proportion of phospholipid class PE in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (d) Proportion of phospholipid class PG in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (e) Proportion of phospholipid class PI in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (f) Proportion of phospholipid class PS in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (g) Proportion of phospholipid class S in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25 to 29+6 weeks of gestation. *P<0.05, male vs. female.

Phospholipid Species

LPC species

An effect of gestational age was observed for the proportions of LPC 16:0, 18:1, 18:2, and 20:4 (Figure 2a, respectively). There was a tendency for the proportions of LPC 14:0 (PA=0.063) and 16:1 (PA=0.070) to change in males and females with gestational age; however, these were not statistically significant (Supplementary Table S1). No overall effects of sex, age, or their interaction were observed for the proportions of LPC 14:0, 16:1, and 18:0; the mean±SEM of the proportions of these species within LPC for each sex at each age is shown in Supplementary Table S1.

Figure 2
figure 2

Proportions of the phospholipid molecular species of LPC. (a) Proportion of the phospholipid molecular species lysophosphatidylcholine (LPC) 16:0 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (b) Proportion of the phospholipid molecular species LPC 18:1 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (c) Proportion of the phospholipid molecular species LPC 18:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (d) Proportion of the phospholipid molecular species LPC 20:4 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation.

PC species

In both sexes combined, the proportion of PC 34:1 (Figure 3d) decreased with gestational age at birth, with the proportion being significantly lower at 28 and 29 weeks compared with that at 25 and 26 weeks. There was a significant age effect in the proportion of PC 32:0 (Figure 3b) such that values were higher at 28 and 29 weeks than at 25 and 26 weeks. In addition, the proportion of PC 32:0 was significantly lower in males than in females at 25 weeks, but it was significantly higher in males than in females at 27 weeks (Figure 3b). The proportions of PC 34:0 (PA=0.079) and 38:2 (PA=0.059) tended to change with age when data from males and females were combined; these proportions were significantly different between males and females at specific gestational ages, with males at 27 weeks having a higher proportion of PC 34:0 (Figure 3c) and a lower proportion of PC 38:2 compared with females (Figure 3h). An interaction effect was also observed for the proportions of PC 30:0, 34:2, 36:2, and 36:3 (Figure 3a, respectively), where proportions of each lipid differed between males and females at specific gestational ages. No significant overall effects of sex or age or interaction effects were observed for the proportions of PC 32:1, 36:1, 38:4, 38:5, 16:0/20:4, and 16:0/22:6; the mean±SEM of the proportions of these species within PC is shown in the Supplemental Data (Supplementary Table S2).

Figure 3
figure 3

Proportions of the phospholipid molecular species of PC. (a) Proportion of the phospholipid molecular species phosphatidylcholine (PC) 30:0 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (b) Proportion of the phospholipid molecular species PC 32:0 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (c) Proportion of the phospholipid molecular species PC 34:0 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (d) Proportion of the phospholipid molecular species PC 34:1 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (e) Proportion of the phospholipid molecular species PC 34:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (f) Proportion of the phospholipid molecular species PC 36:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (g) Proportion of the phospholipid molecular species PC 36:3 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (h) Proportion of the phospholipid molecular species PC 38:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. *P<0.05, male vs. female.

PE species

There was a significant interaction effect in the proportion of PE 36:2 (Figure 4a), indicating that the effect of gestational age on the proportion of this species differed between males and females; there was a strong trend for males to have a lower proportion of PE 36:2 compared with females at 26 weeks of gestation (P=0.051). There were no significant sex, age, or interaction effects in the proportions of the other PE species (34:1, 36:1, 36:3, 36:4, 38:3, 38:4, 38:5, 38:6, 40:4, and 40:6); however, the proportion of PE 34:2 (PA=0.059) tended to change in males and females with gestational age at birth. The mean±SEM of the proportions of these species within PE is shown in Supplementary Table S3.

Figure 4
figure 4

Proportions of the phospholipid molecular species of PE, PI and PS. (a) Proportion of the phospholipid molecular species PE 36:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (b) Proportion of the phospholipid molecular species PI 36:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (c) Proportion of the phospholipid molecular species PI 36:3 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (d) Proportion of the phospholipid molecular species PI 36:4 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (e) Proportion of the phospholipid molecular species PS 36:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. *P<0.05, male vs. female.

PG species

There were no overall effects of sex or age (or their interaction) in the proportions of PG 16:0/18:1 and 18:0/18:1, although there tended to be an interaction effect in the proportion of PG 18:1/18:1 (PS × A=0.064). The mean±SEM of the proportions of these species within PG is shown in Supplementary Table S4.

PI species

The proportions of PI 36:2 (Figure 4b) and PI 36:3 (Figure 4c) in males and females increased with gestational age, with the proportions at 27 and 28 weeks being significantly higher than that at 25 weeks. There was an interaction effect in the proportion of PI 36:4, with males having a significantly higher proportion compared with females at 28 weeks (Figure 4d). No overall sex, age, or interaction effects were observed for the proportions of PI 32:0, 32:1, 34:1, 36:1, 38:3, 38:4, and 40:4; the mean±SEM of the proportions of these species is shown in Supplementary Table S5.

PS species

Males overall had a higher proportion of PS 36:2 than did females (Figure 4e). No overall sex, age, or interaction effects were observed for the proportions of PS 36:1, 38:3, 38:4, 40:5, and 40:6; the mean±SEM of these species is shown in Supplementary Table S6.

S species

Females overall had higher proportions of S 33:1 and S 35:1 than did males (Figure 5b, respectively). When data from both sexes were combined, the proportion of S 33:1 (Figure 5b) decreased with increasing gestational age, with the proportion at 29 weeks being significantly lower than that at 25, 26, and 27 weeks. An interaction effect was observed in the proportions of S 32:1, 33:1, 34:2, 35:1, and 39:1 (Figure 5a, respectively), with males and females exhibiting different age-related changes in proportions. No overall sex, age, or interaction effects were observed in the proportions of the other S species (34:0, 34:1, 36:1, 38:1, 41:1, 41:2, and 42:1); the mean±SEM of the proportions of these species is shown in Supplementary Table S7.

Figure 5
figure 5

Proportions of the phospholipid molecular species of S. (a) Proportion of the phospholipid molecular species S 32:1 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (b) Proportion of the phospholipid molecular species S 33:1 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (c) Proportion of the phospholipid molecular species S 34:2 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (d) Proportion of the phospholipid molecular species S 35:1 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (e) Proportion of the phospholipid molecular species S 39:1 in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. *P<0.05, male vs. female.

Phospholipid Maturity Ratios

The ratio of PC/S was higher in the combined data from all males compared with that in the data from all females (Figure 6a). In the combined data from both sexes, PC/S increased at 27 weeks and 28 weeks compared with that at 25 weeks and 26 weeks, but decreased after 28 weeks (Figure 6a). There was a tendency for PC/S to differ between the sexes at different gestational ages (PS × A=0.064); however, this was not statistically significant (Figure 6a). No overall sex, age, or interaction effects were observed for PI/PG (Figure 6b).

Figure 6
figure 6

Phospholipid maturity ratios. (a) The phospholipid maturity ratio PC/S in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation. (b) The phospholipid maturity ratio PI/PG in gastric aspirate samples from male (closed squares) and female (open circles) infants born at 25–29+6 weeks of gestation.

Discussion

Previous studies have attributed the “male disadvantage” in preterm respiratory function to delayed lung development, in particular a delay in surfactant maturation and production (16, 17). Here we provide evidence showing that the phospholipid components of pulmonary surfactant differ according to gestational age and sex.

Sex Differences in the PC/S Maturity Ratio

Overall, preterm male infants had a greater PC/S ratio than did females, suggesting that males have greater lung surfactant maturity, although this tended to differ according to gestational age at birth. The data suggest that males born at 27 weeks of gestation have a higher PC/S ratio than do females, although this is likely due to a much higher ratio in one male infant compared with the other males at that age. Nonetheless, our data are in contrast to previous studies that have shown that males have a lower PC/S ratio than do females in late gestation. For example, amniotic fluid samples from human pregnancies with male fetuses have a lower PC/S ratio than those with female fetuses from 30 to 40 weeks of gestation (16, 17). A similar sex difference in the PC/S ratio is observed in the amniotic fluid of fetal mice in late gestation (24) and in lung lavage and amniotic fluid samples from fetal rabbits at ~28 weeks of human gestation equivalence (18). Compared with these previous studies, our study was performed on gastric aspirate samples collected from infants soon after birth (rather than samples collected during pregnancy) and who were born at earlier gestational ages. Interestingly, in the bronchoalveolar lavage fluid of male lambs collected at 4 h after preterm birth there was a lower PC/PE ratio (equivalent to the PC/S ratio) than in females (19); however, there was no sex difference in the PC/S ratio in amniotic fluid (19) or in lung liquid (25) prior to preterm birth or in bronchoalveolar lavage fluid collected at 8 h after preterm birth in lambs managed on CPAP (26). In addition, no sex difference in the composition of surfactant is observed in very immature or mature rabbit fetuses (18), or in rhesus monkeys in the last trimester-equivalent (27), suggesting that the timing of sample collection, the species, and potentially the sample source influence the data.

Sex Differences in the Composition of PC

The most abundant phospholipid species within PC and the phospholipid with the greatest ability to reduce surface tension within the lungs in most mammals is the disaturated phospholipid DPPC (PC 32:0) (20). The proportion of PC 32:0 in the gastric aspirate of males was lower than that in females at 25 weeks of gestation but higher in males than in females at 27 weeks, suggesting that males born at 25 weeks may be more vulnerable to respiratory distress than would females of the same age. Previous studies in humans have reported that the concentration of saturated PC and the proportion of disaturated PC are lower in amniotic fluid from pregnancies with males than with females between 30 and 40 weeks of gestation (16, 17). Based on the observed sex differences in the proportion of saturated PCs in the human fetus, it is likely that there may be windows of increased vulnerability for males compared with females in terms of their ability to reduce surface tension at the air–liquid interface.

Previous studies in different animal models have shown conflicting data with regard to sex differences in PC composition. As in humans, disaturated PC content in late-gestation fetal rats is greater in the lungs of females than in males (14). In contrast, no sex difference in disaturated PC is observed in non-human primates in the last-trimester equivalent (27) or in fetal rabbits at an age that equates to ~28 weeks of human gestation (28). Similarly, there are no sex differences in PC composition in near-term mice (24), in sheep fetuses (19, 25), or in preterm lambs that are spontaneously breathing and managed on CPAP (26) or anesthetized and ventilated (29). Conversely, spontaneously breathing male preterm lambs not managed on CPAP have lower proportions of DPPC and PC than do females (19). These studies suggest that timing of sample collection is an important consideration when evaluating phospholipid composition.

The proportions of the saturated PCs 30:0 (PC 16:0/14:0; palmitoyl-myristoyl PC) and 34:0 (PC 16:0/18:0; palmitoyl-stearoyl PC) and the unsaturated PCs 34:2 (PC 16:0/18:2; palmitoyl-linoleoyl PC), 36:2 (PC 18:1/18:1; dioleoyl PC), 36:3, and 38:2 in gastric aspirate differed between preterm males and females at different gestational weeks of birth. Although the role of each of these individual PC species is unclear, it is known that saturated PCs help reduce surface tension at the air–liquid interface because of their molecular structure, namely their ability to be tightly packed (30). In contrast, unsaturated PCs are less able to reduce surface tension, although they are more fluid at body temperature; this characteristic enables greater surface film respreading and adsorption to the air–liquid interface (20). Therefore, alterations in PC composition can alter the surfactant properties. There are few data on sex differences in specific molecular species of PC (other than DPPC); however, a previous study in preterm lambs found higher proportions of PC 34:2 and PC 36:2 in the bronchoalveolar lavage fluid of males than in those of females at 4 h after delivery (19). In the present study, the proportion of PC 36:2 was higher in males born at 25 weeks of gestation compared with that in females; however, it was greater in females born at 26 and 27 weeks of gestation. PC 34:2 and PC 36:2 are considered to be plasma PCs, and an increase in plasma PCs may indicate a decreased ability for surfactant to lower surface tension in the lungs as plasma proteins are known to inhibit surfactant function (31). Overall, based on our data on PC composition, it is possible that males born at 25 weeks of gestation are more vulnerable than females to surfactant dysfunction, whereas females are more vulnerable at 27 weeks of gestation.

Sex Differences in Acidic Phospholipids

PG and PI are anionic phospholipids that are thought to be important in enhancing the surface activity of DPPC by promoting its adsorption to the air–liquid interface; PG is also stipulated to have other roles (30). It has previously been reported that PG is produced late in gestation (16, 27, 28, 32, 33); thus, PG or the PI/PG ratio is often used as an indicator of lung maturity (32). In humans, PG reportedly first appears in amniotic fluid at 34 weeks of gestation in females and at 35 weeks in males, and the rate of increase in the proportion of PG is higher in females than in males (16). In the present study, there were no sex differences in the proportion of PG or in the PI/PG ratio; however, because of the earlier gestational ages examined, PG was detected at very low levels. Similarly, there is no apparent sex difference in the proportion of PG in sheep prior to preterm delivery or soon after preterm delivery, although the levels of PG are also low at this age (19, 25, 26). In contrast to PG, the proportion of PI in amniotic fluid reportedly increases from 28 weeks of gestation in humans and then gradually decreases after 36 weeks (33), with female fetuses having levels lower than those of males after 37 weeks (16). In fetal rabbits, males tend to have a lower proportion of PI in lung lavage than females at 0.9 of term, but at term, male fetuses tend to have a higher proportion of PI and a lower proportion of PG than females (28). In contrast, there is no sex difference in the proportion of PI in sheep prior to or soon after preterm delivery (19, 25, 26). In the present study, preterm males had a higher proportion of PI than did females, which was most apparent at 26 and 27 weeks of gestation. Since previous studies have indicated a rise in PI levels after 28 weeks of gestation (33), the higher proportion of PI in males at the earlier gestational ages examined in our study could be beneficial in reducing surface tension; however, experimental studies suggest that increasing the proportion of PI in surfactant has no significant effect on surfactant function (20).

Sex Differences in the Composition of Other Phospholipids

Preterm males had a lower proportion of total S in their gastric aspirate than did females, which was most evident at 27 weeks of gestation; the lower proportion of S contributes to the higher PC/S ratio observed in preterm males as there was no sex difference in the proportion of PC. Sphingomyelin is found in cellular membranes and is a minor component of surfactant itself; it is usually only used as a reference for the measurement of PC production rather than being perceived to have a role in surfactant function (32). However, there are studies in which an increase in the levels of “membrane phospholipids” has been associated with lung injury (20). PE is also considered to be a membrane phospholipid that is present in surfactant (20), although unlike sphingomyelin, no significant sex difference in PE proportion was observed in the present study. Compared with females, preterm males also had a higher proportion of PS 36:2 in gastric aspirate, a lower proportion of S 33:1, and a lower proportion of S 35:1, which was most notable at 26 and 27 weeks of gestation. It is unknown whether these differences in phospholipid composition are likely to result in alterations in surfactant function as the specific roles of these phospholipid species are not clear.

Changes in Phospholipid Composition with Age

The proportions of numerous phospholipid species changed with increasing gestational age in both males and females: LPC 16:0, LPC 18:1, LPC 18:2, LPC 20:4, PC 32:0, PC 34:1, PI 36:2, PI 36:3, and S 33:1. In addition, the proportion of S and consequently the PC/S ratio were altered by gestational age in male and female preterm infants. As expected, PC/S increased with advancing gestational age, indicating increasing lung maturity. The proportion of PC 32:0 was greater at 28 and 29 weeks than at 25 and 26 weeks of gestation, also suggesting an improvement in surfactant function (i.e., surface tension lowering ability) with advancing gestational age. In contrast, the proportion of PC 34:1 (PC 16:0/18:1; palmitoyl-oleoyl PC) decreased with increasing gestation despite being one of the major unsaturated PCs in surfactant. The proportions of each of the aforementioned LPC species were differentially altered by age; although the functions of these specific LPC species are unknown, it is known that LPC is associated with lung injury (34). The significance of changes in the proportions of PI 36:2, PI 36:3, and S 33:1 across different gestational ages at birth is unknown.

Further Considerations

Numerous studies have suggested a differential sex effect of glucocorticoids on neonatal outcomes (11, 12, 35) and on surfactant phospholipid composition (28, 29, 36). Furthermore, antenatal corticosteroids have been shown to influence maturation of the antioxidant defense system, particularly in preterm females who showed greater antioxidant enzyme activity and less oxidative stress than preterm males (37). Importantly, pro-oxidant status can alter surfactant composition and influence lung vascular reactivity, which may predispose preterm infants to poor respiratory adaptation after birth (38). Hence, it would be of interest to compare the surfactant phospholipid profile of preterm males and females with regard to antenatal glucocorticoid administration; however, in the present study only 2/89 infants did not receive any antenatal corticosteroid treatment. Furthermore, chorioamnionitis and mode of delivery may influence surfactant production (39, 40). Further studies are required to relate differences in the surfactant phospholipid profile of preterm males and females to neonatal respiratory outcomes. It is important to note that, although gastric aspirate is likely to contain pulmonary surfactant soon after birth, not all phospholipids detected in the samples may be attributable to pulmonary surfactant, and the method of phospholipid detection can be sensitive to contamination of samples (e.g., with blood, saliva, or nasal secretions) (32).

Conclusions

Our study shows that the phospholipid composition of gastric aspirate from preterm males differs from that of preterm females and this is dependent on the gestational age at birth. We conclude that there are likely to be periods of increased vulnerability to respiratory distress in preterm males compared with females, in particular at lower gestational ages at birth.